GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $16.60 $19.00 Thursday, 18th Apr 2024 ACAD stock ended at $17.07. This is 0.698% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 1.97% from a day low at $17.01 to a day high of $17.35.
90 days $16.60 $29.29
52 weeks $16.60 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
2023-12-29 $31.70 $31.80 $31.18 $31.31 1 261 781
2023-12-28 $31.66 $31.92 $31.26 $31.39 895 430
2023-12-27 $31.12 $31.93 $30.75 $31.77 1 251 428
2023-12-26 $31.75 $31.75 $31.10 $31.13 911 169
2023-12-22 $30.10 $32.59 $30.07 $31.40 2 324 033
2023-12-21 $29.56 $29.92 $28.97 $29.52 1 182 467
2023-12-20 $30.08 $30.31 $29.00 $29.05 1 599 338
2023-12-19 $30.20 $30.47 $29.09 $30.13 2 550 035
2023-12-18 $28.50 $29.37 $28.15 $29.02 1 878 622
2023-12-15 $28.30 $29.45 $27.94 $28.58 4 397 661
2023-12-14 $27.24 $28.80 $27.22 $28.06 2 860 914
2023-12-13 $21.50 $28.94 $21.41 $28.47 14 073 864
2023-12-12 $21.31 $21.39 $20.76 $21.17 2 115 661
2023-12-11 $21.17 $21.26 $20.88 $21.09 1 442 012
2023-12-08 $21.73 $21.73 $20.87 $20.98 1 382 196
2023-12-07 $21.51 $21.84 $21.20 $21.79 2 814 714
2023-12-06 $22.48 $22.56 $21.20 $21.38 1 317 631
2023-12-05 $22.69 $22.70 $22.18 $22.29 1 119 927
2023-12-04 $22.52 $23.06 $22.42 $22.85 1 115 261
2023-12-01 $22.35 $22.76 $22.07 $22.60 1 193 998
2023-11-30 $22.40 $22.49 $22.03 $22.28 1 316 670
2023-11-29 $22.40 $22.50 $22.03 $22.13 750 728
2023-11-28 $22.16 $22.29 $21.87 $22.29 927 384
2023-11-27 $22.19 $22.28 $21.59 $22.12 881 878
2023-11-24 $22.02 $22.30 $21.86 $22.29 528 656
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT